Stratasys has launched its 3D printed RadioMatrix technology in the US, allowing clinicians to create radio-realistic models. Made of radiopaque material, RadioMatrix provides control over radiopacity, enabling the production of patient-specific models with adjustable visibility on X-ray imaging for training and surgical planning. This advancement aims to enhance imaging education and research environments.

In collaboration with Siemens Healthineers, Stratasys demonstrated that 3D printed RadioMatrix ‘phantoms’ closely replicate human tissue in CT imaging, with minimal deviations in critical areas. These anatomically realistic, radio-accurate phantoms preserve fine details and variations specific to patients, aiding in validating and optimizing CT protocols for precise diagnosis and treatment planning.

The medical 3D printing market is projected to grow at a CAGR of 21%, reaching $4bn in 2026. Beyond imaging training, 3D printing in healthcare is revolutionizing surgical planning and assistance. Studies have shown that using 3D anatomic models as surgical guides reduces time by 62 minutes and saves $3,720 per case, driving cost-effective and efficient healthcare solutions.

Stratasys is collaborating with CollPlant Biotechnologies to develop 3D-printed breast implants and working with FluidForm Bio to advance the 3D printing of human cardiac tissue using FRESH technology. These partnerships showcase the innovative applications of 3D printing in healthcare, expanding possibilities for personalized and effective medical solutions.

Read more at Yahoo Finance: Stratasys completes US rollout of 3D-printed imaging support material